North America Human Liver Models Market

The North America human liver models market is expected to grow from US$ 98,522.08 thousand in 2021 to US$ 2,08,998.55 thousand by 2028; it is estimated to grow at a CAGR of 11.3% from 2021 to 2028. The US, Canada, and Mexico are economies in North America. Rising prevalence of liver diseases is expected to fuel the North America human liver models market growth. The liver is the body's largest internal organ and performs over 500 functions. Liver toxicity is a major concern in risk assessment as the liver is exposed to most xenobiotic compounds and their bioactive metabolites, making it susceptible to chemically induced liver disease. Hepatitis C virus (HCV), chronic hepatitis B virus (HBV), nonalcoholic fatty liver disease (NAFLD), and alcohol-associated liver disease (ALD) are among the leading causes of chronic liver disease. Viral hepatitis continues to be the leading cause of death cases caused by liver failure, and at the same time, the NAFLD has become one of the fastest-growing contributors to liver morbidity and associated mortality. Chronic liver diseases such as NAFLD or chronic hepatitis infections are associated with an elevated risk of primary liver cancer—hepatocellular carcinoma (HCC). Cirrhosis is well known and is the leading cause of HCC, with an incidence of ~0.5 million and a 5-year survival rate of 10%. According to recent estimates, the incidence of this cancer has been increasing at an alarming rate, making HCC the fifth most common cancer in men and the seventh most common cancer in women. The HCC likely contributes to ~5.6% of all human cancers, thereby increasing the burden in 2020. The HCC is known to be the second leading cause of cancer-related deaths across the region. Other types of liver cancer are cholangiocellular carcinoma (CCC), a malignant disease of the liver bile ducts, and hepatoblastoma. Hepatoblastoma is the most common malignant tumor of liver in children. Thus, a rise in the prevalence of liver diseases, including chronic and acute diseases and microbial infections, increases the demand for liver models across North America region. According to the Centers for Disease Control and Prevention (CDC), patients with chronic liver disease or who are immunocompromised are at a higher risk of severe sickness from COVID-19. The rapid rise in reported COVID-19 cases in the US necessitated widespread changes in healthcare practices across the country. Although organ transplantation is frequently a medical emergency, the growing demand for and use of hospital resources has negatively affected transplant centers' ability to perform these life-saving procedures. COVID-19-related issues have hampered liver transplantation in the region, posing a threat to the human liver models market over the anticipated period. With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America human liver models market. The North America human liver models market is expected to grow at a good CAGR during the forecast period. North America Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand) North America Human Liver Models Market Segmentation North America Human Liver Models Market By Type - Liver Organoids - Liver-on-a-chip - 2D Models - 3D Bioprinting - Others North America Human Liver Models Market By Application - Drug Discovery - Educational - Others North America Human Liver Models Market By End User - Pharmaceutical and Biotechnology Companies - Research Institutes - Others North America Human Liver Models Market, by Country - US - Canada - Mexico North America Human Liver Models Market -Companies Mentioned - BioIVT - CELLINK - Emulate, Inc. - InSphero - Kerafast - MIMETAS BV - ORGANOVO HOLDINGS INC. - THERMO FISHER SCIENTIFIC INC.

North America Human Liver Models Strategic Insights

Strategic insights for the North America Human Liver Models provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Human Liver Models Report Scope

North America Human Liver Models Regional Insights

The geographic scope of the North America Human Liver Models refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.